TREM2 and triple-A syndrome: By combining CRISPR‐MI with single‐cell RNA sequencing (scRNA‐Seq), this study finds that Triggering receptor expressed on myeloid cells 2 (Trem2) is a negative regulator of monocyte infiltration into the aortic wall in early AAA induction.